Sabyasachi Roy

CEO & Managing Director

The oral healthcare products market is experiencing a technology-led disruption driven by increasingly knowledgeable and ingredient-conscious consumers, who demand evidence-based products and not merely flashy TVCs and marketing. While traditional herbal and natural formulated products are still widely prevalent in India, there is a growing interest in modern science-based actives like nano-hydroxyapatite, bioactive glass, and effective fluoride-free formulations.

Ceramat, a specialist in innovative bioceramics, is bridging this gap with a science-first and manufacturing-led approach. Today, the firm is known in the market for meticulously devising exclusive nano-hydroxyapatite and bioactive ceramics of oral-care grade. The nHAp, as they are known in the brand space, is India’s only customized, European Union SCCS-compliant, and vegan active material made in India for the World.

Advancing Oral Healthcare through Precision Bioceramic Solutions

Ceramat has positioned itself as a category-defining force in the oral healthcare materials ecosystem of India by providing a complete range of high-purity bioceramic actives aligned with the global trend towards regenerative healthcare solutions. As opposed to traditional oral care ceramic ingredient providers who rely on imports or low-grade products, the company manufactures end-to-end medical and pharmaceutical-grade products backed by scientifically verified & traceable specifications, international safety standards, and tailored formulation services.

Ceramat’s core offering is nano-hydroxyapatite (n-HAp), which is uniquely offered on a commercial scale in both powder and slurry form - a global first from the same manufacturer. As an EU SCCS (Scientific Committee on Consumer Safety)-compliant material and produced with full process traceability. n-HAp not only facilitates remineralization but also helps to achieve the results of anti-sensitivity, enamel strengthening, cavity filling, nonbleaching whitening, and non-abrasive cleaning whitening in next-generation dentrifices. Ceramat’s portfolio also includes micronized Hydroxyapatite, bioactive glass, and enamel-like validation discs, allowing brands to develop evidence-based oral product claims by conducting robust clinical and lab-grade testing and analysis of toothpaste, mouthwashes and oral gels.

Ceramat’s flexible production strategy serves brands at all levels - right from concept development to scaleup. A zero-Minimum Order Quantity (MOQ) policy enables both emerging and large-scale brands to receive the same unwavering standard of quality, paperwork, and manufacturing accuracy. Each batch of material is differentiated by particle morphology, surface coating, crystallinity, solubility, and use case. This supply chain ease has brought in multiple new entrants in the remineralization toothpaste (fluoride-composite or fluoride free) manufacturing space, thus fueling a growth in indigenous oral care enablers both in contract manufacturing as well as brand ownership.

Beyond materials, Ceramat is a go-to formulation partner. Its R&D support services include technical dossiers, entire array of characterization tests, toxicology tests, dentifrice testing & analysis, compatibility mapping, ingredient customization, and regulatory documentation aligned with international standards.

Even in an era dominated by automation buzzwords, the firm prioritizes science-led manufacturing backed by unmatched human expertise. The first set of products and publications from Ceramat were co-invented with collaboration from Tata Steel R&D and Indian Institute of Science, thus setting the epitome of scientific standards. As Sabyasachi Roy, CEO and Managing Director, states, “We innovate only where it truly benefits the product and the end-user. Automation supports our accuracy, but experience drives purity and consistency. Our responsibility is not just to manufacture materials it is to ensure they perform reliably in the hands of formulators.”

Reimagining Oral Care Through Science

Going forward, the firm is gearing towards its next stage of growth, where it is planning on expanding its presence in Europe, the UK, and other key export markets. The firm is also expanding its portfolio beyond Hydroxyapatite and Bioactive glasses to other complementary bioceramic materials like Zirconia and rare earth ceramics, with the view to providing a whole ecosystem of innovative oral care solutions. Ceramat has its origin in ceramicists and material scientists with elected members of the Indian Ceramics Society among its founding members. So the germ of its origin has always been in quality ingredients for healthcare. Hence, quality has been the primary focus while tailoring to market needs. One of Ceramat’s most promising upcoming directions lies in nutrition and therapeutic applications. Ceramat is also formulating an orally available Calcium supplement made of Hydroxyapatite, positioning it as a superior alternative to traditional Calcium salts.

In conjunction with this, Di- Calcium Phosphate, Tri-Calcium Phosphate, and Octa- Calcium Phosphate are being studied as both active and excipient agents. Ceramat has already established an active commercial arm on orthopaedic & dental bioceramics catering to medical hard tissue implantables and the company already is ISO 13485 compliant along with REACH, vegan and halal certification. The overarching vision of the company remains in providing accessible and affordable biomaterial solutions made in India for the World and eventually completely substituting imports.

Ceramat’s future roadmap is guided by a clear principle: not to be a consumer-facing brand, but a technology enabler for consumer goods and pharmaceutical manufacturers. It aims to enable the entire oral care industry to innovate with science-backed, latest, and clinically relevant ingredients, thus promoting Indian Innovation and Indian manufacturing, for the World.